A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham...

Area of Science:

• Neuroscience
• Virology
• Oncology

Background:

• Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease of the central nervous system.
• PML is primarily caused by the John Cunningham virus (JCV), often in immunocompromised individuals.
• Hematologic malignancies, such as chronic lymphocytic leukemia (CLL), are significant risk factors for developing PML.

Observation:

• A 67-year-old female patient with a history of CLL presented with seizures.
• Clinical presentation, brain MRI, and biopsy results were indicative of JCV-induced PML.
• The patient was treated with mefloquine (250 mg/day) without observable clinical improvement.

Findings:

• This case report details a patient with CLL who developed JCV-induced PML.
• Mefloquine treatment at 250 mg/day did not lead to clinical improvement in this patient.
• The lack of effective treatments underscores the poor prognosis of JCV-induced PML.

Implications:

• The case emphasizes the challenges in managing JCV-induced PML, particularly in patients with underlying hematologic malignancies.
• It highlights the need for novel therapeutic strategies for PML.
• Further research is warranted to explore effective treatments for this devastating neurological condition.